retatrutide clinical trials sign up How to Get in 2026 Where to Get Retatrutide: Investigational

PolitiFact Staff Researcher Caryn Baird contributed to this report

In most cases, adults may qualify for GLP-1 weight loss medications with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, prediabetes, high cholesterol, sleep apnea, or cardiovascular disease

It is currently only available within clinical trial settings and is being evaluated for the treatment of obesity and type 2 diabetes

Pharmaceutical-grade peptide powders stored in freezers without auto-defrost functionality can maintain stability for three or more years confirmed, with potential longevity extending to ten years under optimal conditions